vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and Vroom, Inc. (VRM). Click either name above to swap in a different company.
Vroom, Inc. is the larger business by last-quarter revenue ($235.9M vs $151.7M, roughly 1.6× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -59.8%, a 67.6% gap on every dollar of revenue. On growth, Vroom, Inc. posted the faster year-over-year revenue change (12.9% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $-108.8M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -49.5%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Vroom, Inc. is a parent company of United Auto Credit Corporation (UACC) and CarStory. Previously, Vroom was a used car retailer and e-commerce company that let consumers buy, sell, and finance cars online. Vroom ceased e-commerce automotive sales operations on January 22, 2024.
NUTX vs VRM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $235.9M |
| Net Profit | $11.8M | $-141.1M |
| Gross Margin | 30.4% | 12.3% |
| Operating Margin | 20.4% | -11.5% |
| Net Margin | 7.8% | -59.8% |
| Revenue YoY | -41.1% | 12.9% |
| Net Profit YoY | -80.8% | -669.8% |
| EPS (diluted) | $2.34 | $-80.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | — | ||
| Q3 25 | $267.8M | — | ||
| Q2 25 | $244.0M | — | ||
| Q1 25 | $211.8M | — | ||
| Q4 24 | $257.6M | — | ||
| Q3 24 | $78.8M | — | ||
| Q2 24 | $76.1M | — | ||
| Q1 24 | $67.5M | — |
| Q4 25 | $11.8M | — | ||
| Q3 25 | $55.4M | — | ||
| Q2 25 | $-17.7M | — | ||
| Q1 25 | $21.2M | — | ||
| Q4 24 | $61.6M | — | ||
| Q3 24 | $-8.8M | — | ||
| Q2 24 | $-364.0K | — | ||
| Q1 24 | $-364.0K | — |
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — | ||
| Q1 24 | 15.1% | — |
| Q4 25 | 20.4% | — | ||
| Q3 25 | 48.7% | — | ||
| Q2 25 | 13.8% | — | ||
| Q1 25 | 38.1% | — | ||
| Q4 24 | 44.4% | — | ||
| Q3 24 | 12.3% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | 2.1% | — |
| Q4 25 | 7.8% | — | ||
| Q3 25 | 20.7% | — | ||
| Q2 25 | -7.3% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 23.9% | — | ||
| Q3 24 | -11.2% | — | ||
| Q2 24 | -0.5% | — | ||
| Q1 24 | -0.5% | — |
| Q4 25 | $2.34 | — | ||
| Q3 25 | $7.76 | — | ||
| Q2 25 | $-2.95 | — | ||
| Q1 25 | $3.33 | — | ||
| Q4 24 | $11.56 | — | ||
| Q3 24 | $-1.72 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $135.6M |
| Total DebtLower is stronger | — | $454.2M |
| Stockholders' EquityBook value | $329.4M | $127.7M |
| Total Assets | $918.5M | $1.5B |
| Debt / EquityLower = less leverage | — | 3.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | — | ||
| Q3 25 | $166.0M | — | ||
| Q2 25 | $96.7M | — | ||
| Q1 25 | $84.7M | — | ||
| Q4 24 | $40.6M | — | ||
| Q3 24 | $46.9M | — | ||
| Q2 24 | $40.8M | — | ||
| Q1 24 | $30.0M | — |
| Q4 25 | $329.4M | — | ||
| Q3 25 | $317.2M | — | ||
| Q2 25 | $235.3M | — | ||
| Q1 25 | $176.9M | — | ||
| Q4 24 | $132.4M | — | ||
| Q3 24 | $60.4M | — | ||
| Q2 24 | $62.7M | — | ||
| Q1 24 | $63.0M | — |
| Q4 25 | $918.5M | — | ||
| Q3 25 | $964.5M | — | ||
| Q2 25 | $841.0M | — | ||
| Q1 25 | $761.9M | — | ||
| Q4 24 | $655.3M | — | ||
| Q3 24 | $438.5M | — | ||
| Q2 24 | $422.4M | — | ||
| Q1 24 | $404.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $-108.1M |
| Free Cash FlowOCF − Capex | $69.0M | $-108.8M |
| FCF MarginFCF / Revenue | 45.5% | -46.1% |
| Capex IntensityCapex / Revenue | 0.9% | 0.3% |
| Cash ConversionOCF / Net Profit | 5.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $-536.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | — | ||
| Q3 25 | $99.5M | — | ||
| Q2 25 | $27.3M | — | ||
| Q1 25 | $51.0M | — | ||
| Q4 24 | $54.0K | — | ||
| Q3 24 | $6.8M | — | ||
| Q2 24 | $13.3M | — | ||
| Q1 24 | $3.1M | — |
| Q4 25 | $69.0M | — | ||
| Q3 25 | $99.2M | — | ||
| Q2 25 | $26.5M | — | ||
| Q1 25 | $50.9M | — | ||
| Q4 24 | $-341.0K | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $12.7M | — | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 45.5% | — | ||
| Q3 25 | 37.0% | — | ||
| Q2 25 | 10.9% | — | ||
| Q1 25 | 24.0% | — | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 16.7% | — | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
VRM
Segment breakdown not available.
